2-(4-Bromo-2-chloro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

(3aS,4R,5S,6aR)-5-Hydroxy-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one, 95.0%, 1g

1,2-benzisothiazole, 95.0%, 250mg

3-Chloro-4-methoxypyridine, 95.0%, 100mg

2-(4-Methoxycyclohexyl)ethylamine (cis- and trans- mixture)>98.0%(GC)(T)1g

2-METHOXY-3,5-DIMETHYL-PYRIDIN-4-AMINE, 95%, 500mg

3,5-Difluoro-2,4-dimethoxyaniline, 250mg

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(6-{[({amino[(4-chlorophenyl)amino]methylidene}amino)methanimidoyl]amino}hexyl)methanimidamide; bis(acetic acid), 25g

(5-(Benzyloxy)-2-formylphenyl)boronic acid, 96%, 100mg

5-Bromo-2-(piperidin-1-yl)pyridine, 95.0%, 10g

3,5,5-Trimethylhexanoic Acid>98.0%(T)25mL

6-tert-Butyl-4,5,6,7-tetrahydrobenzothiazol-2-ylamine, 1g

(9H-FLUOREN-9-YL)METHYL 2-OXOPYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg